Neuraxis, INC SEC filings NRXS
Neuraxis, INC has 193 filings in SEC EDGAR's recent list, going back to Sep 27, 2022. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 3, 2026 | — |
| EFFECT | Filing | Feb 11, 2025 | — |
| CORRESP | Letter to the SEC | Feb 7, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2024 | — |
| NT 10-Q | Filing | May 15, 2024 | Mar 31, 2024 |
| NT 10-K | Filing | Apr 1, 2024 | Dec 31, 2023 |
| NT 10-Q | Filing | Nov 14, 2023 | Sep 30, 2023 |
| EFFECT | Filing | Aug 8, 2023 | — |
| CERT | Nyse american certification | Aug 8, 2023 | — |
| 8-A12B | Filing | Aug 8, 2023 | — |
| CORRESP | Letter to the SEC | Aug 4, 2023 | — |
| CORRESP | Letter to the SEC | Aug 4, 2023 | — |
| CORRESP | Letter to the SEC | Jul 28, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 26, 2023 | — |
| CORRESP | Letter to the SEC | Feb 15, 2023 | — |
| CORRESP | Letter to the SEC | Feb 15, 2023 | — |
| CORRESP | Letter to the SEC | Feb 14, 2023 | — |
| CORRESP | Letter to the SEC | Feb 14, 2023 | — |
| CORRESP | Letter to the SEC | Feb 13, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 13, 2023 | — |
| CORRESP | Letter to the SEC | Feb 6, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 1, 2023 | — |
| CORRESP | Letter to the SEC | Jan 26, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 24, 2023 | — |
| CORRESP | Letter to the SEC | Jan 10, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 19, 2022 | — |
| DRS/A | Filing | Dec 12, 2022 | — |
| DRSLTR | Filing | Dec 9, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 22, 2022 | — |
| DRSLTR | Filing | Nov 9, 2022 | — |
| DRS/A | Filing | Nov 9, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 24, 2022 | — |
| DRS | Filing | Sep 27, 2022 | — |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- NRXS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Carmel, IN
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1933567
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.